Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, specializing in the development of innovative antibody-based therapies aimed at addressing various forms of cancer and other serious diseases. With a strong focus on advancing its proprietary drug candidates through rigorous clinical trials, Compass is committed to leveraging its cutting-edge technology platform to create highly targeted treatments that enhance patient outcomes. The company's pipeline reflects its dedication to transforming the oncology landscape, making it a noteworthy prospect for institutional investors seeking exposure to breakthrough medical advancements in oncology.
Click "Analyze" to generate stock analysis
CMPX Price Trend and Signals
CMPX Option Volumes & Open Interests (aggregated)
CMPX Put Call Ratios and IV (aggregated)
CMPX Financials
2025-10-22Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-22Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-22Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-22Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.